Cullinan Oncology LLC (CGEM)
Healthcare
Biotechnology
16.50 $
-5.8%
vs. previous close
Closing price · As of: 31. Jul 2026
Cullinan Oncology LLC (CGEM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -176 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2013 | 2014 | 2015 | 2016 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.7 | -0.1 | 0.0 | -0.2 | -14 | -21 | -30 | -43 | -127 | -134 | -145 | -176 | |
| – | – | – | – | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | 0.3 | 0.3 | |
| – | – | – | – | – | 0.0 | 15 | 24 | 28 | 30 | 38 | 36 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | -0.4 | 15 | 24 | 28 | – | – | – | |
| – | – | – | – | 0.3 | 0.1 | 6.9 | -3.5 | 11 | -0.3 | -0.4 | 14 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | 0.0 | 0.6 | 1.1 | 0.2 | 0.0 | 0.0 | |
| – | – | – | – | -0.3 | -35 | -5.4 | -334 | 249 | 36 | -136 | 180 | |
| 1.0 | 1.0 | 1.0 | 1.0 | 0.0 | -0.4 | -0.2 | 271 | -24 | – | – | – | |
| 0.7 | 0.1 | 0.0 | -0.8 | – | 0.2 | 0.2 | 0.2 | -2.2 | 1.8 | 0.0 | – | |
| 0.7 | 0.1 | 0.0 | 0.2 | 0.0 | 86 | 140 | 269 | -26 | 41 | 266 | 1.1 | |
| 0.0 | 0.0 | 0.0 | 0.0 | -14 | 29 | 105 | -108 | 96 | -58 | -15 | 5.3 | |
| – | – | – | – | -14 | -21 | -30 | -44 | -128 | -134 | -145 | -176 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.